Last reviewed · How we verify

NCT04448730

Polycystic Ovary Syndrome and BETATROPHIN

Completed Last updated 26 June 2020
What this trial tests

trial testing serum marker levels in Polycystic Ovary in 73 participants. Completed in 30 December 2019.

Timeline
1 January 2018
Primary endpoint
30 July 2019
30 December 2019

Quick facts

Lead sponsorHatice Akkaya
StatusCompleted
Study typeOBSERVATIONAL
Enrollment73
Start date1 January 2018
Primary completion30 July 2019
Estimated completion30 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hatice Akkaya

Who can join

Adults 18 to 40, female only, with Polycystic Ovary or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an original study giving an information about the association body mass index, polycystic ovary syndrome and betatrophin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of serum marker levels

Trials testing the same drug.

Other recruiting trials for Polycystic Ovary

Currently open trials in the same condition.

Other Hatice Akkaya trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04448730.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing